ALPHAMAB-B(09966) announces profit expectation, expected to achieve annual profit for the first time in 2024 with profits of no less than 150 million yuan.
Kangning Jerui Pharmaceuticals - B (09966) announced that the group is expected to end on December 31, 2024...
ALPHAMAB-B (09966) announced that the group is expected to achieve a profit of no less than RMB 150 million for the year ending December 31, 2024, while it incurred a loss of approximately RMB 210.6 million for the year ending December 31, 2023. This marks the first time the company has achieved an annual profit.
The announcement stated that the company has turned a loss into a profit during the reporting period, mainly due to three authorized cooperation and sales revenue.
Related Articles

Guojin Hwen Ask Non-ferrous Metals: Supply Contraction and AI Demand Resonance, Non-ferrous Sector "CommodityStock" Value Transmission in Progress.

Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.

Boeing Company (BA.US) has received approval from the FAA to increase the monthly production limit of 737 MAX aircraft to 42.
Guojin Hwen Ask Non-ferrous Metals: Supply Contraction and AI Demand Resonance, Non-ferrous Sector "CommodityStock" Value Transmission in Progress.

Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.

Boeing Company (BA.US) has received approval from the FAA to increase the monthly production limit of 737 MAX aircraft to 42.

RECOMMEND